PMV Pharmaceuticals, Inc.PMVPNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
5.04%
↓ 79% below average
Average (6y)
24.34%
Historical baseline
Range
High:53.23%
Low:0.00%
Volatility
218.7%
High variability
| Period | Value |
|---|---|
| 2024 | 5.04% |
| 2023 | 5.72% |
| 2022 | 42.80% |
| 2021 | 53.23% |
| 2020 | 13.76% |
| 2019 | 49.85% |
| 2018 | 0.00% |